GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Fortrea Holdings Inc.
Fortrea, spun off from Labcorp, is one of the world's largest contract research organizations (CROs). Its stock price reflects the trend toward outsourcing clinical trials by pharmaceutical companies, but also the challenges associated with establishing an independent and effective business.
Share prices of companies in the market segment - Pharma tests
Fortrea, a spinoff from Labcorp, is one of the world's largest contract research organizations (CROs) supporting clinical trials. We classify it as part of the Pharma Testing sector, and the chart below reflects the dynamics of the entire industry, which depends on pharmaceutical R&D spending.
Broad Market Index - GURU.Markets
Fortrea is a major contract research organization (CRO) that provides clinical trial services to pharmaceutical and biotech companies. As a component of the GURU.Markets index, it is a key partner for the pharmaceutical industry. The chart below represents the entire market. See how Fortrea shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
FTRE - Daily change in the company's share price Fortrea Holdings Inc.
Change_co for Fortrea, a contract research organization (CRO), reflects sensitivity to R&D spending in the pharmaceutical industry. Daily fluctuations reflect the response to activity in the clinical trials sector. This metric is important for analyzing biotech service companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma tests
Fortrea Holdings Inc. is a contract research organization (CRO). This chart shows the average daily volatility of the healthcare sector. Comparison with FTRE, a spinoff from Labcorp, helps to assess it as a pure-player in this market.
Daily change in the price of a broad market stock, index - GURU.Markets
Fortrea, a spinoff from Labcorp, is one of the world's largest contract research organizations (CROs). Its business serves as a barometer of activity in the global pharmaceutical industry. The chart below shows general market fluctuations, which can be used to assess Fortrea's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Fortrea Holdings Inc.
Fortrea, spun out of Labcorp, is now one of the world's largest contract research organizations (CROs). Its annual growth rate serves as a barometer of R&D investment in the pharmaceutical and biotech industries.
Annual dynamics of market capitalization of the market segment - Pharma tests
Fortrea Holdings Inc., spun off from Labcorp, is one of the world's largest contract research organizations (CROs). Its mission is to prove its effectiveness as a standalone company. The chart below shows how its scale, global reach, and dependence on pharmaceutical R&D budgets impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Fortrea, as a contract research organization (CRO), is a gold mine for biotech. Demand for its services is stable, as drug development continues. The company's stock performance since its spinoff demonstrates the resilience typical of companies providing scientific infrastructure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Fortrea Holdings Inc.
Fortrea, a contract research organization (CRO) spun off from Labcorp, is driven by R&D cycles in the pharmaceutical industry. The monthly fluctuations on the chart reflect the demand for clinical trial outsourcing from pharmaceutical and biotech companies.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Contract research organizations (CROs) are the backbone of the pharmaceutical industry. Their sector dynamics, reflected in the graph, are directly related to the volume of R&D spending in biotech. In this environment, major players like Fortrea help bring new drugs to market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Fortrea, a contract research organization (CRO), serves the pharmaceutical industry. Demand for its services depends on the industry's R&D volumes, making it relatively stable. The company's stock can exhibit volatility not always associated with short market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Fortrea Holdings Inc.
The weekly performance of Fortrea, a contract research organization (CRO) spun out of Labcorp, reflects the state of the pharmaceutical industry. News about clinical trial outsourcing, the size of pharmaceutical companies' R&D budgets, and the competitive landscape among CROs shape its performance.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Fortrea and the entire contract research organization (CRO) sector depend on the overall R&D spend in the pharmaceutical industry. The trend toward clinical trial outsourcing is a tailwind for everyone. The chart below shows how the recently spun-off company from Labcorp competes in this market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Fortrea's shares, as a company serving the biotech sector, can rise even during a market decline if biotech funding remains strong. Its performance depends on R&D cycles, not general economic trends. The chart will reveal this potential miscorrelation.
Market capitalization of the company, segment and market as a whole
FTRE - Market capitalization of the company Fortrea Holdings Inc.
Fortrea's market capitalization chart is the financial history of a new, large contract research organization (CRO) spun out of Labcorp. It reflects investors' attempts to assess its prospects as an independent company. Its initial dynamics are a barometer of the state of the clinical research outsourcing market and the confidence in the new team's ability to succeed.
FTRE - Share of the company's market capitalization Fortrea Holdings Inc. within the market segment - Pharma tests
Fortrea Holdings is a major contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its market share reflects its global scale. The chart shows the company's importance as a key partner in the drug development process.
Market capitalization of the market segment - Pharma tests
Fortrea is a large contract research organization (CRO) spun off from Labcorp. The chart below shows the total market capitalization of the entire pharmaceutical testing sector, reflecting the scale of outsourcing in drug development. As a major player in the pharmaceutical industry, Fortrea is a strategic partner.
Market capitalization of all companies included in a broad market index - GURU.Markets
The clinical trials visible in the chart are often outsourced. Fortrea Holdings, a spinoff from Labcorp, is one of the largest contract research organizations (CROs). Its market capitalization reflects its scale and ability to help pharmaceutical companies bring new drugs to market.
Book value capitalization of the company, segment and market as a whole
FTRE - Book value capitalization of the company Fortrea Holdings Inc.
The book value of Fortrea, spun off from Labcorp, represents the legacy foundation for clinical trials. The chart reflects the value of the global network of laboratories, offices, and technology platforms that help pharmaceutical companies develop new drugs.
FTRE - Share of the company's book capitalization Fortrea Holdings Inc. within the market segment - Pharma tests
Fortrea Holdings, a contract research organization spun out of Labcorp, inherited significant global infrastructure. Its stake in the sector's assets includes laboratories, clinics, and operational centers. This infrastructure allows it to conduct complex clinical trials for pharmaceutical companies.
Market segment balance sheet capitalization - Pharma tests
Fortrea is a large contract research organization (CRO). Its model is distinct from the capital-intensive pharmaceutical industry it serves. Its assets are not manufacturing plants, but a global network of laboratories and clinical centers.
Book value of all companies included in the broad market index - GURU.Markets
Fortrea Holdings is a contract research organization (CRO) spun out of Labcorp. It helps pharmaceutical companies conduct clinical trials. Its net worth is its global network of laboratories, offices, and trial management technology platforms.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Fortrea Holdings Inc.
Fortrea Holdings is a contract research organization (CRO). The premium placed on its assets (laboratories) reflects its scale, its long-term relationships with pharmaceutical companies, and its key role in the drug discovery ecosystem.
Market to book capitalization ratio in a market segment - Pharma tests
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. It's a service business. The chart shows that the market values its expertise, reputation, and contracts with pharmaceutical giants significantly more than its tangible assets.
Market to book capitalization ratio for the market as a whole
Fortrea Holdings is a contract research organization (CRO) spun out of Labcorp that helps pharmaceutical companies conduct clinical trials. Compared to average market valuations shown in this chart, its valuation is based on the level of R&D spending in the pharmaceutical industry.
Debts of the company, segment and market as a whole
FTRE - Company debts Fortrea Holdings Inc.
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. It is a services business, but it may use debt to acquire other CROs or invest in data analytics technology to improve efficiency and expand the range of services it offers its clients.
Market segment debts - Pharma tests
Fortrea Holdings, spun off from Labcorp, is a large contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This business requires significant investment in personnel and technology. This chart shows the company's initial debt load after its spinoff.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Fortrea Holdings Inc.
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart shows its debt load. Debt levels are important because they can impact the company's ability to invest in new technologies and personnel to remain competitive in the pharmaceutical R&D outsourcing market.
Market segment debt to market segment book capitalization - Pharma tests
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its business depends on the volume of R&D activity in the pharmaceutical industry. This chart shows the overall debt burden in the sector, allowing one to assess how Fortrea finances its operations and growth compared to its peers.
Debt to book value of all companies in the market
Fortrea Holdings Inc. is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. It's a service business, but its growth may require investment in technology and labs. This chart provides an overview of how Fortrea is using its balance sheet for expansion, relative to overall funding trends in the healthcare sector.
P/E of the company, segment and market as a whole
P/E - Fortrea Holdings Inc.
This chart shows the valuation of Fortrea, a contract research organization (CRO). Its P/E ratio reflects the high demand for clinical trial outsourcing from pharmaceutical companies. This is a bet that drug development will become increasingly complex and expensive, which will support a steady flow of orders for companies like Fortrea.
P/E of the market segment - Pharma tests
Fortrea Holdings is a global contract research organization (CRO) spun out of Labcorp. The company helps pharmaceutical and biotech companies conduct clinical trials of new drugs. This chart shows the average score for the CRO sector, a key part of the drug development ecosystem, and provides an overview of Fortrea's position.
P/E of the market as a whole
Fortrea Holdings, spun off from Labcorp, is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its business depends on the volume of R&D in the pharmaceutical industry. This general sentiment trend influences biotech funding, but for Fortrea, the long-term trend toward outsourcing clinical research is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Fortrea Holdings Inc.
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its revenue is driven by its R&D investments in the pharmaceutical industry. This chart reflects market expectations regarding Fortrea's future drug development activity and its ability to win new contracts.
%20P%2FE%20Fortrea%20Holdings%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Fortrea-Holdings-Inc.&v=1772702385236 "Chart of the company's future (projected) P/E Fortrea Holdings Inc.")
Future (projected) P/E of the market segment - Pharma tests
Fortrea Holdings, spun off from Labcorp, is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart shows general expectations for the healthcare sector. FTREA's position relative to the average reflects market opinion on their ability to compete for contracts in this important industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772702385252 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Fortrea Holdings Inc. is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its business depends on the volume of R&D investment in the pharmaceutical industry. This market optimism chart indirectly reflects investor willingness to fund biotech, leading to increased orders for CROs.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772702385265 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Fortrea Holdings Inc.
Fortrea Holdings, spun off from Labcorp, is a global contract research organization (CRO) providing clinical trial services to pharmaceutical and biotech companies. Its revenue, shown in the graph, depends on the number and scale of drug research contracts.
Profit of companies in the market segment - Pharma tests
Fortrea Holdings, spun off from Labcorp, is a global contract research organization (CRO) providing clinical development services to the pharmaceutical and biotech industries. This chart shows the overall profitability of the pharmaceutical testing sector. It reflects the volume of R&D investment by pharmaceutical companies, which directly drives Fortrea's business.
Overall market profit
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Demand for its services depends on the volume of R&D investment in the pharmaceutical industry. The growth in overall market revenue, shown in the graph, creates a favorable environment, allowing biopharmaceutical companies to spend more on research, which increases Fortrea's order book.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Fortrea Holdings Inc.
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its revenue is driven by the volume of R&D outsourced within the industry. This chart shows analysts' expectations for future revenue, reflecting their views on drug development activity.
%20profit%20of%20the%20company%20Fortrea%20Holdings%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Fortrea-Holdings-Inc.&v=1772702385306 "Graph of future (projected) profit of the company Fortrea Holdings Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its revenue is driven by R&D investment in the global pharmaceutical industry. This chart shows profitability projections for the entire sector, allowing you to assess how Fortrea benefits from outsourcing R&D.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772702385317 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Demand for its services depends on the level of R&D investment in the pharmaceutical industry. This schedule may be indirectly affected, as the overall state of the economy impacts biotech companies' ability to attract funding.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772702385322 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Fortrea Holdings Inc.
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its revenue is driven by the volume of research outsourced to the pharmaceutical industry. This chart shows how investors view its position in the competitive CRO market and overall R&D spending trends.
P/S market segment - Pharma tests
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Revenue comes from fees for research management services. This CRO sector chart helps assess how the market views Fortrea's scale, expertise, and reputation in drug development.
P/S of the market as a whole
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. The company's revenue is driven by its R&D investments in the pharmaceutical industry. This chart shows how the market values revenue overall, which helps understand the valuation of this important outsourcing business.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Fortrea Holdings Inc.
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart shows how investors estimate future revenue from research contracts. It reflects their expectations for R&D investment in the global pharmaceutical industry.
%20P%2FS%20Fortrea%20Holdings%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Fortrea-Holdings-Inc.&v=1772702385340 "The graph of the company's future (projected) P/S Fortrea Holdings Inc.")
Future (projected) P/S of the market segment - Pharma tests
Fortrea Holdings was spun out of Labcorp as an independent contract research organization (CRO) providing clinical trial services to pharmaceutical and biotech companies. The company's valuation reflects investor expectations regarding the growth of R&D outsourcing in the pharmaceutical industry and its ability to compete with other large CROs.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772702385351 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its business serves as a barometer of R&D activity. The revenue growth expectations shown here depend on the drugs Fortrea is currently testing.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772702385353 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Fortrea Holdings Inc.
Fortrea Holdings is a global contract research organization (CRO) spun out of Labcorp. Revenues reported here are generated by providing Phase I-IV clinical trial services to pharmaceutical and biotech companies, helping them bring new drugs to market.
Sales of companies in the market segment - Pharma tests
Fortrea Holdings (FTRE) is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of new drugs. It was spun off from Labcorp. This figure reflects revenue in the pharmaceutical testing sector, where Fortrea plays a critical role in bringing new drugs to market.
Overall market sales
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its business depends on the volume of investment in the development of new drugs. This general economic activity pattern influences risk appetite and the availability of capital for R&D in the pharmaceutical industry, which directly determines Fortrea's order book.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Fortrea Holdings Inc.
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its revenue is driven by the volume of R&D outsourcing in the pharmaceutical industry. This chart shows analyst revenue expectations, which is an indicator of investment activity in the biotech sector.
%20sales%20of%20the%20company%20Fortrea%20Holdings%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Fortrea-Holdings-Inc.&v=1772702385405 "Schedule of future (projected) sales of the company Fortrea Holdings Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Fortrea Holdings is a global contract research organization (CRO) spun out of Labcorp. It helps pharmaceutical and biotech companies conduct clinical trials. The forecast in this chart segments future revenue by clinical trial phase or therapeutic area, reflecting R&D activity.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772702385417 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Fortrea Holdings is a global contract research organization (CRO) spun out of Labcorp. It provides clinical trial services to pharmaceutical and biotech companies. This graph, reflecting the investment climate in biopharma, influences R&D spending, which shapes Fortrea's market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772702385422 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Fortrea Holdings Inc.
Fortrea Holdings, spun off from Labcorp, is a global contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. The company's profitability depends on the volume of research outsourced to the pharmaceutical industry. The chart shows how Fortrea generates revenue by providing critical services for drug development.
Market segment marginality - Pharma tests
#VALUE!
Market marginality as a whole
Fortrea Holdings is a contract research organization (CRO) providing services to the pharmaceutical and biotech industries. Demand for its services depends on the volume of R&D in these industries. This overall profitability chart indirectly reflects the investment climate. Rising margins in the economy stimulate investment in new drug development, increasing orders for Fortrea.
Employees in the company, segment and market as a whole
Number of employees in the company Fortrea Holdings Inc.
Fortrea Holdings is a large contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. The size of its team is enormous and directly reflects its ability to manage hundreds of clinical trials simultaneously. This chart illustrates its global operational capacity.
Share of the company's employees Fortrea Holdings Inc. within the market segment - Pharma tests
Fortrea Holdings is one of the world's largest contract research organizations (CROs), helping pharmaceutical companies conduct clinical trials. Its core business is providing services, and its main asset is its vast staff of specialists. This figure directly reflects its global scale and ability to manage hundreds of complex clinical trials simultaneously.
Number of employees in the market segment - Pharma tests
Fortrea Holdings is a global contract research organization (CRO) that facilitates clinical trials for pharmaceutical companies. The employment landscape in this sector directly reflects the volume and complexity of R&D in the global pharmaceutical industry. The growth of its specialist workforce is a direct driver of Fortrea's business, as more and more companies outsource clinical trials.
Number of employees in the market as a whole
Fortrea is a contract research organization providing clinical development services to the biopharmaceutical industry. Its growth is driven by pharmaceutical companies' R&D spending. Overall economic health, as shown in this chart, influences the funding conditions for the drug development it supports.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Fortrea Holdings Inc. (FTRE)
Fortrea Holdings is a large contract research organization (CRO) that conducts clinical trials for pharmaceutical companies. This business requires a large staff of highly qualified specialists. This metric helps assess the company's operational efficiency, reputation, and ability to attract large contracts, which ultimately determines its value.
%20of%20the%20company%20Fortrea%20Holdings%20Inc.%20(FTRE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Fortrea-Holdings-Inc.-FTRE&v=1772702385491 "Chart of market capitalization per employee (in thousands of dollars) of the company Fortrea Holdings Inc. (FTRE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Fortrea Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its value lies in expertise and effectiveness in managing complex research. This chart shows how the market evaluates each Fortrea employee's ability to effectively manage projects and generate revenue.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772702385494 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart shows how the market values a business based on expertise. Value is created by a team of scientists and project managers managing complex and lengthy studies worldwide.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772702385496 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Fortrea Holdings Inc. (FTRE)
Fortrea Holdings is a large contract research organization (CRO) spun off from Labcorp. They help pharmaceutical companies conduct clinical trials. It's a service business whose main asset is thousands of qualified specialists. This chart shows how effectively the company manages projects and personnel, generating revenue from R&D services.
%20Chart%20Fortrea%20Holdings%20Inc.%20(FTRE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Fortrea-Holdings-Inc.-FTRE&v=1772702385513 "Company Profit Per Employee (in thousands of dollars) Chart Fortrea Holdings Inc. (FTRE)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Fortrea Holdings is a large contract research organization (CRO) spun out of Labcorp. They help pharmaceutical companies conduct clinical trials. It's a service business, with thousands of scientists and project managers managing trials. This metric reflects how cost-effectively the company can manage these complex projects.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772702385517 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Fortrea Holdings is a large contract research organization (CRO) spun out of Labcorp. Fortrea conducts clinical trials for pharmaceutical and biotech companies. It's a service-based, science-intensive business, requiring a large staff of highly qualified specialists (physicians, scientists, and managers). This metric helps assess how effectively a CRO manages its most important asset—its people—to generate revenue from its services.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772702385520 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Fortrea Holdings Inc. (FTRE)
Fortrea Holdings is a global contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Revenue per employee is a direct indicator of the productivity of its scientists and project managers. The chart reflects the volume and complexity of the research conducted for clients.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Fortrea-Holdings-Inc.-FTRE&v=1772702385528 "Sales chart per company employee Fortrea Holdings Inc. (FTRE)")
Sales per employee in the market segment - Pharma tests
Fortrea (FTRE) is a large contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart shows the average revenue per employee in the segment. It allows you to evaluate how effectively Fortrea manages projects and staff compared to other CRO competitors.
Sales per employee for the market as a whole
Fortrea Holdings (FTRE) is a large contract research organization (CRO) that was spun off from Labcorp. FTRE helps pharmaceutical and biotech companies conduct clinical trials. It's a service business, where revenue directly depends on the work of thousands of specialists worldwide. This metric reflects the company's revenue generated per employee involved in the complex drug development process.
Short shares by company, segment and market as a whole
Shares shorted by company Fortrea Holdings Inc. (FTRE)
Fortrea (FTRE) is a large contract research organization (CRO) that was spun off from Labcorp. It helps pharmaceutical companies conduct clinical trials. This chart measures short interest. The rise in this indicator may be related to concerns about a slowdown in R&D spending in the biotech sector or profitability issues that arose after the spinoff. (348)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Fortrea-Holdings-Inc.-FTRE&v=1772702385579 "Short Shares Chart for the Company Fortrea Holdings Inc. (FTRE)")
Shares shorted by market segment - Pharma tests
Fortrea is a contract research organization (CRO) spun off from LabCorp. It helps pharmaceutical companies conduct clinical trials. This chart reflects the overall sentiment in the sector, reflecting investor concerns that biotechs will cut spending on R&D and clinical trials.
Shares shorted by the overall market
Fortrea (FTRE) is a contract research organization (CRO) that conducts clinical trials for pharmaceutical companies. Its business depends on biotech R&D budgets. When this chart shows rising fears, "venture winter" freezes funding for small biotechs. They are the first to cancel or postpone trials, which hurts FTRE's order book.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Fortrea Holdings Inc. (FTRE)
Fortrea is a major contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its stock is a barometer of biotech R&D budgets. This chart measures when the market is overbought on expectations of an R&D boom or oversold on fears that startups are cutting their trial budgets.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Fortrea-Holdings-Inc.-FTRE&v=1772702385624 "RSI 14 indicator chart for the company's stock Fortrea Holdings Inc. (FTRE)")
RSI 14 Market Segment - Pharma tests
Fortrea is a large contract research organization (CRO), recently spun off from Labcorp. Their business is providing clinical trial services to pharmaceutical giants. This chart reflects the overall sentiment in the CRO sector. It helps investors understand whether Fortrea's move is part of a broader industry trend (driven by R&D budgets) or is unique.
RSI 14 for the overall market
Fortrea (FTRE), a contract research organization (CRO), sees this chart as a proxy for the budgets of its biotech clients. During periods of market euphoria, biotechs readily raise capital and immediately spend it on clinical trials, commissioning them from FTRE. During periods of panic, R&D funding freezes, and trial projects are postponed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast FTRE (Fortrea Holdings Inc.)
Fortrea Holdings is a large contract research organization (CRO) spun out of Labcorp. The company helps pharmaceutical and biotech companies conduct clinical trials of new drugs. This chart shows analysts' 12-month price target for FTRE stock.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-FTRE-Fortrea-Holdings-Inc.&v=1772702385682 "A chart showing analyst consensus forecasts for the expected stock price. FTRE (Fortrea Holdings Inc.)")
The difference between the consensus estimate and the actual stock price FTRE (Fortrea Holdings Inc.)
Fortrea is a large contract research organization (CRO) recently spun off from Labcorp. Their business focuses on assisting pharmaceutical and biotech companies with clinical trials (from Phase 1 to Phase 4). This chart shows how analysts estimate future R&D budgets in biopharma and their ability to win contracts.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-FTRE-Fortrea-Holdings-Inc.&v=1772702385700 "A chart showing the difference between the consensus forecast and the actual stock price. FTRE (Fortrea Holdings Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Fortrea Holdings (FTRE) is the former clinical trials arm of Labcorp. Fortrea helps pharmaceutical companies conduct clinical trials. This chart shows analysts' overall expectations for the pharma testing sector. It reflects whether experts believe R&D outsourcing will grow in Big Pharma.
Analysts' consensus forecast for the overall market share price
Fortrea Holdings is a large contract research organization (CRO) spun out of Labcorp. They help pharmaceutical companies conduct clinical trials of new drugs. This chart shows overall market sentiment. For Fortrea, whose business relies on R&D spending in the pharmaceutical sector (considered defensive), the overall optimism is important, but their growth is more dependent on biotech R&D budgets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Fortrea Holdings Inc.
Fortrea, a recently spun-off division of Labcorp, is one of the world's largest contract research organizations (CROs). Their business is managing complex and expensive clinical trials (from Phase I to IV) for pharmaceutical and biotech companies. This chart is a barometer of R&D spending in the industry, reflecting the size of their backlog (order portfolio) for future research.
AKIMA Market Segment Index - Pharma tests
Fortrea (FTRE) is a global Contract Research Organization (CRO) giant (spinned off from Labcorp); the company is a key outsourcer for pharmaceutical companies, helping them conduct complex clinical trials. This aggregate metric evaluates companies. The graph shows the average value for the segment. This benchmark: how does this large-scale service (CRO) model (FTRE) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Fortrea is a contract research organization (CRO) spun out of Labcorp. It conducts clinical trials for biopharmaceutical companies. This chart, which reflects the market average, provides context. It helps assess how FTRE, a drug development partner, compares to overall macroeconomic trends and industry R&D spending.
